FindTrial
Sign In

Hematopoietic stem cell infusion

BIOLOGICAL5 trials

Sponsors

Baylor College of Medicine, Talaris Therapeutics Inc., Masonic Cancer Center, University of Minnesota, Rafic Farah, MD

Conditions

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaAdrenoleukodystrophy (ALD and AMN)Alpha-mannosidosisChronic Myelogenous LeukemiaHematologic DiseasesHunter Syndrome (MPS II)Hurler Syndrome (MPS I)

Phase 1

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
TerminatedNCT00579111
Baylor College of MedicineAcute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia +5
Start: 2007-06-30End: 2010-10-31Updated: 2016-05-04
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
TerminatedNCT01372228
Talaris Therapeutics Inc.Adrenoleukodystrophy (ALD and AMN), Alpha-mannosidosis, Hunter Syndrome (MPS II) +9
Start: 2011-04-30End: 2016-04-30Updated: 2023-04-12
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
CompletedNCT02167958
Rafic Farah, MDLeukemia, Lymphoma, MDS +1
Start: 2015-02-11End: 2019-09-21Updated: 2019-10-15

Unknown Phase

MIBG for Refractory Neuroblastoma and Pheochromocytoma
CompletedNCT01850888
Masonic Cancer Center, University of MinnesotaMetastatic Pheochromocytoma, Relapsed Neuroblastoma
Start: 2013-12-31End: 2025-10-20Updated: 2025-12-18
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
RecruitingNCT02161783
Masonic Cancer Center, University of MinnesotaPrimary Graft Failure, Secondary Graft Failure
Start: 2014-10-06End: 2032-01-30Target: 50Updated: 2026-01-06